1.0Trade Brains Featureshttps://tradebrains.in/featuresPTI Newshttps://tradebrains.in/features/author/ptinews/Zydus Lifesciences gets final USFDA approval for drug to treat high uric acidrich600338<blockquote class="wp-embedded-content" data-secret="ApjXkdbcHY"><a href="https://tradebrains.in/features/biz-zydus-usfda-7/">Zydus Lifesciences gets final USFDA approval for drug to treat high uric acid</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://tradebrains.in/features/biz-zydus-usfda-7/embed/#?secret=ApjXkdbcHY" width="600" height="338" title="“Zydus Lifesciences gets final USFDA approval for drug to treat high uric acid” — Trade Brains Features" data-secret="ApjXkdbcHY" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://tradebrains.in/features/wp-content/uploads/2022/05/Zydus-Cover-Image.jpg1280854Zydus Lifesciences Ltd on Tuesday said it has received final approval from the US health regulator to market its generic version of Febuxostat tablets used to treat high uric acid in the blood.